Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
Authors:
Open Access
- 1 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Abstract
Hyperphosphatemia and hypoalbuminemia confer worse clinical outcomes, whether these risk factors interact to predispose to mortality is unclear. In this prospective cohort study, 2,118 patients undergoing incident continuous ambulatory peritoneal dialysis (CAPD) were enrolled and categorized into four groups based on the changing point regarding mortality at 1.5 mmol/L for serum phosphorus and 35 g/L for serum albumin. Risks of all-cause and cardiovascular mortality were examined independently and interactively in overall and subgroups. There was no association between serum phosphorus with all-cause and cardiovascular mortality, but significant interactions (p = 0.02) between phosphorus and albumin existed in overall population. Patients in subgroup with high phosphorus and low albumin were at greater risk of all-cause (HR 1.95, 95%CI 1.27–2.98, p = 0.002) but not cardiovascular mortality (HR 0.37, 95%CI 0.10–1.33, p = 0.13), as compared to those with low phosphorus and high albumin. In contrast, patients with both low parameters had a higher risk of all-cause (HR 1.75, 95%CI 1.22–2.50, p = 0.002) and cardiovascular mortality (HR 1.92, 95%CI 1.07–3.45, p = 0.03). Notably, an elevated risk of both all-cause and cardiovascular mortality was observed in those with low serum albumin, irrespective of phosphorus levels, suggesting low albumin may be useful to identify a higher-risk subgroup of patients undergoing CAPD with different serum phosphorus levels.Keywords
This publication has 46 references indexed in Scilit:
- Interaction of Time-Varying Albumin and Phosphorus on Mortality in Incident Dialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Serum Albumin as a Predictor of Mortality in Peritoneal Dialysis: Comparisons With HemodialysisAmerican Journal of Kidney Diseases, 2011
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Prescribed Dietary Phosphate Restriction and Survival among Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2011
- Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis populationNephrology Dialysis Transplantation, 2010
- Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?The American Journal of Clinical Nutrition, 2008
- Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2006
- Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal studyKidney International, 2006
- The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis PatientsAmerican Journal of Kidney Diseases, 2005
- Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKDAmerican Journal of Kidney Diseases, 2005